NIH-funded research R01 grant

Using AI to create libraries for chemical synthesis

Official title: Generative AI for retrosynthesis libraries

Funded at Ohio State University · NIH-11009576 · Data updated 2026-11-12

This study is exploring new ways to use artificial intelligence to help scientists break down complex molecules into simpler parts, which could speed up the creation of new medicines that might help patients like you.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startJanuary 9, 2024
Project endNovember 30, 2027
Funding year2025
Award (this year)$297,004
NIH project number5R01LM014385-02
Project IDNIH-11009576 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for benefiting from this research include individuals with conditions that require new drug therapies or those involved in clinical trials for novel medications.

Less likely to help

Patients who are not seeking new treatments or those with conditions that are already well-managed with existing therapies may not benefit from this research.

What this research studies

This research focuses on developing advanced artificial intelligence techniques to improve the process of retrosynthesis, which is the method of breaking down complex molecules into simpler components for drug development. By utilizing generative AI, the project aims to create diverse libraries of synthetic reactions that can efficiently produce target molecules through one-step reactions. The approach involves innovative deep learning methods, specifically graph neural networks, to accurately represent molecular structures and automate the synthesis process. Patients may benefit indirectly from this research as it could lead to faster and more effective drug discovery.

Why it matters

Potential benefit: If successful, this research could significantly accelerate the development of new drugs, leading to improved treatment options for patients.

How similar studies have gone: Other research has shown promise in using AI for drug discovery, indicating that this approach could lead to significant advancements in the field.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Ning, Xia — Ohio State University
  • Study coordinator: Ning, Xia

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.